688317 之江生物
按盤價 
20.120 -0.230 (-1.130%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -0.836 | -3.416 | -3.411 | 18.941 | 28.678 |
| 總資產報酬率 ROA (%) | -0.782 | -3.242 | -3.104 | 16.898 | 24.731 |
| 投入資產回報率 ROIC (%) | -0.809 | -3.393 | -3.368 | 18.639 | 28.019 | 邊際利潤分析 |
| 銷售毛利率 (%) | 62.625 | 60.946 | 65.123 | 51.645 | 62.483 |
| 營業利潤率 (%) | -30.471 | -81.536 | -54.495 | 39.005 | 44.636 |
| 息稅前利潤/營業總收入 (%) | -63.338 | -155.391 | -88.002 | 34.123 | 44.281 |
| 淨利潤/營業總收入 (%) | -32.486 | -71.347 | -49.887 | 32.682 | 37.573 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 200.735 | -12.316 | -7.354 | 94.693 | 98.460 |
| 價值變動淨收益/利潤總額(%) | -10.814 | -0.038 | 0.000 | 0.000 | 0.000 |
| 營業外收支淨額/利潤總額(%) | -6.238 | 3.258 | 4.555 | -0.652 | -0.530 | 償債能力分析 |
| 流動比率 (X) | 23.063 | 20.108 | 13.383 | 7.463 | 8.687 |
| 速動比率 (X) | 22.650 | 19.715 | 12.311 | 6.501 | 7.954 |
| 資產負債率 (%) | 8.792 | 4.039 | 6.118 | 11.456 | 10.042 |
| 帶息債務/全部投入資本 (%) | 5.819 | 0.359 | 0.499 | 1.184 | 1.069 |
| 股東權益/帶息債務 (%) | 1,616.802 | 27,694.865 | 19,878.514 | 8,310.048 | 9,211.110 |
| 股東權益/負債合計 (%) | 1,037.353 | 2,376.067 | 1,534.554 | 772.931 | 895.781 |
| 利息保障倍數 (X) | 1.828 | 2.185 | 2.847 | -7.370 | -370.356 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 137.559 | 158.301 | 216.341 | 34.287 | 39.719 |
| 存貨周轉天數 (天) | 439.234 | 802.259 | 1,425.308 | 128.576 | 102.473 |
| 備註： | 即時報價更新時間為 12/12/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
